On August 29, 2018 Audentes Therapeutics, Inc. (Nasdaq : BOLD ), a biotechnology company focused on developing and commercializing innovative gene therapy products for patients living with serious, life-threatening rare diseases, reported that it will participate in the following investor conferences in September (Press release, Audentes Therapeutics, AUG 29, 2018, View Source [SID1234529130]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Citi’s 13th Annual Biotech ConferenceMatthew R. Patterson, Chief Executive OfficerFormat: 1×1 Investor MeetingsWednesday, September 5, 2018Boston, Massachusetts

Morgan Stanley 16th Annual Global Healthcare Conference Natalie Holles, President and Chief Operating

OfficerFormat: Fireside ChatWednesday, September 12, 2018, at 8:10am ETNew York, New York
To access a live webcast of the Morgan Stanley Global Healthcare Conference fireside chat, please visit the Events & Presentations page within the Investors + Media section of the Audentes website. A replay of the live webcast will be available on the Audentes website for approximately 30 days following the conference.

On August 29, 2018 SCYNEXIS, Inc. (NASDAQ : SCYX ), a biotechnology company delivering innovative therapies for difficult-to-treat and often life-threatening infections, reported that the Company will participate in the following upcoming investor conferences (Press release, Scynexis, AUG 29, 2018, View Source [SID1234529129]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Baird’s 2018 Global Healthcare Conference at the InterContinental New York Barclay Hotel on Wednesday, September 5, 2018 at 2:00 p.m. ET.

The H.C. Wainwright 20th Annual Global Investment Conference at the St. Regis New York on Thursday, September 6, 2018 at 12:30 p.m. ET.

The Oppenheimer Fall Summit at the Langham, New York, Fifth Avenue on Wednesday, September 26, 2018.

A live webcast of the Baird and HC Wainwright presentations will be available on the Investors section of the Company’s website: www.scynexis.com. Replay of the presentations will be available approximately two hours after each event and will be available for two weeks following each presentation.

On August 29, 2018 Conatus Pharmaceuticals Inc. (Nasdaq:CNAT), a biotechnology company focused on the development and commercialization of novel medicines to treat liver disease, reported that it has been invited to present at the BioCentury 25th Annual NewsMakers in the Biotech Industry Conference on Friday, September 7, 2018, in New York (Press release, Conatus Pharmaceuticals, AUG 29, 2018, View Source [SID1234529128]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Steven Mento, Ph.D., President and Chief Executive Officer of Conatus, is scheduled to present a corporate overview and business update at 10:30 a.m. ET. A webcast of the presentation will be available live and archived in the Investors section of the company’s website at www.conatus.com.

Host BioCentury handpicks only 48 companies to present their stories to biotech sector institutional investors. At the NewsMakers conference held in 2017, more than 500 delegates congregated at NewsMakers, including money managers who controlled more than $600 billion in equity assets, with over $50 billion dedicated to healthcare and $15 billion dedicated to biotech.

On August 29, 2018 Bellicum Pharmaceuticals, Inc. (Nasdaq:BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers and orphan inherited blood disorders, reported that senior management will participate in two upcoming healthcare investor conferences (Press release, Bellicum Pharmaceuticals, AUG 29, 2018, View Source [SID1234529127]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Conference Details:

Event: Citi’s 13th Annual Biotech Conference
Date: Wednesday, September 5, 2018
Location: Boston, MA

Event: 2018 Wells Fargo Securities Healthcare Conference
Date/Time: Thursday, September 6, 2018 at 10:55 a.m. EDT
Location: Boston, MA

A live webcast of the presentation at Wells Fargo may be accessed from the News & Events section of the Bellicum website. An archived version of the webcast will be available for replay for at least two weeks following the event.

On August 29, 2018 BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) reported that the company will present at the Baird Global Healthcare Conference in New York on Thursday, September 6, 2018 at 2:35 p.m. ET (Press release, BioCryst Pharmaceuticals, AUG 29, 2018, http://ir.biocryst.com/news-releases/news-release-details/biocryst-pharmaceuticals-present-baird-global-healthcare [SID1234529126]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Links to a live audio webcast and replay of this presentation may be accessed in the Investors section of BioCryst’s website at http://www.biocryst.com.